Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 134 record(s)

Req # A-2021-001868

Information regarding the status of the Health Canada file on this company. Company: Automobiles Rod-Ham Inc. (NEQ: 1161757787) 600-630 Saint-Paul Street West, Montreal, Quebec, H3C 1L9.

Organization: Health Canada

0 page(s)
February 2022

Req # A-2021-001885

The briefing binder/books and/or transition materials prepared for the new Minister of Health, the Hon. Jean-Yves Duclos.

Organization: Health Canada

553 page(s)
February 2022

Req # A-2021-001898

Information regarding the status of the Health Canada file on this company. Company: Les Cales Sèches Verreault Inc. (1149775463).

Organization: Health Canada

0 page(s)
February 2022

Req # A-2021-001899

Information regarding the status of the Health Canada file on this company. Company: Les Équipements Verreault Inc. (NEQ: 1142870592), 108 Rue du Collège, Les Méchins, Quebec, G0J 1T0.

Organization: Health Canada

0 page(s)
February 2022

Req # A-2021-001940

All communications between Janssen Inc., Janssen Ortho Inc. and their affiliates (collectively “Janssen”), Janssen’s agents or counsel, or Innovative Medicines Canada, its agents or counsel, and Health Canada, (including but not limited to the Office of Patented Medicines and Liaison (OPML) and the Central Nervous System Division (CNSD)) relating to: the product monograph for Teva’s generic version of INVEGA SUSTENNA; and the degree of similarly and allowed difference between the product monograph for INVEGA SUSTENNA (the Canadian Reference Product) and the product monograph for Teva’s generic drug product, including with respect to recommended dosing of the drug.

Organization: Health Canada

0 page(s)
February 2022

Req # A-2019-000551

Adverse Drug Reactions (ADRs) for ONDANSETRON. Report numbers: 721787, 722181, 722762, 723064, 723077, E2B_02265193, E2B_02267272, E2B_02269549, E2B_02278629, E2B_02294917, E2B_02306671 E2B_02306963, E2B_02310903, E2B_02311518, E2B_02312237, E2B_02313523, E2B_02326951, E2B_02335335, E2B_02336874, E2B_02342080, E2B_02348167, E2B_02378377, E2B_02410698, E2B_02420192, E2B_02431526.

Organization: Health Canada

315 page(s)
February 2022

Req # A-2019-001508

Adverse Drug Reactions (ADRs). Report numbers: 000722619, E2B_02581711, E2B_02578676, 000724834, E2B_02490456, E2B_02702480, E2B_02543606, E2B_02595468, E2B_02439146, E2B_01971223, E2B_01955026, E2B_01971468, E2B_01975127 E2B_01975402, E2B_01986048, E2B_02013766, E2B_02038042, E2B_02045530, E2B_02056112, E2B_02064312.

Organization: Health Canada

192 page(s)
February 2022

Req # A-2019-002054

Adverse Drug Reaction (ADR). Report number: E2B_02803860.

Organization: Health Canada

13 page(s)
February 2022

Req # A-2019-002063

Adverse Drug Reaction (ADR) for IXAZOMIB. Report number: E2B_02897412.

Organization: Health Canada

19 page(s)
February 2022

Req # A-2020-000009

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_02579328, E2B_02582914, E2B_02585300, E2B_02525751, E2B_00749104, E2B_02526229, E2B_02511290, E2B_01777639, E2B_02589763, E2B_02515457, E2B_02535912, E2B_02515576, E2B_02516803, E2B_02531115, E2B_02621109.

Organization: Health Canada

337 page(s)
February 2022
Date modified: